Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity
-
Published:2023-11-29
Issue:1
Volume:15
Page:
-
ISSN:1756-994X
-
Container-title:Genome Medicine
-
language:en
-
Short-container-title:Genome Med
Author:
Lin Sheng-Jia, Vona Barbara, Lau Tracy, Huang Kevin, Zaki Maha S., Aldeen Huda Shujaa, Karimiani Ehsan Ghayoor, Rocca Clarissa, Noureldeen Mahmoud M., Saad Ahmed K., Petree Cassidy, Bartolomaeus Tobias, Abou Jamra Rami, Zifarelli Giovanni, Gotkhindikar Aditi, Wentzensen Ingrid M., Liao Mingjuan, Cork Emalyn Elise, Varshney Pratishtha, Hashemi Narges, Mohammadi Mohammad Hasan, Rad Aboulfazl, Neira Juanita, Toosi Mehran Beiraghi, Knopp Cordula, Kurth Ingo, Challman Thomas D., Smith Rebecca, Abdalla Asmahan, Haaf Thomas, Suri Mohnish, Joshi Manali, Chung Wendy K., Moreno-De-Luca Andres, Houlden Henry, Maroofian Reza, Varshney Gaurav K.ORCID
Abstract
Abstract
Background
Biallelic variants in OGDHL, encoding part of the α-ketoglutarate dehydrogenase complex, have been associated with highly heterogeneous neurological and neurodevelopmental disorders. However, the validity of this association remains to be confirmed. A second OGDHL patient cohort was recruited to carefully assess the gene-disease relationship.
Methods
Using an unbiased genotype-first approach, we screened large, multiethnic aggregated sequencing datasets worldwide for biallelic OGDHL variants. We used CRISPR/Cas9 to generate zebrafish knockouts of ogdhl, ogdh paralogs, and dhtkd1 to investigate functional relationships and impact during development. Functional complementation with patient variant transcripts was conducted to systematically assess protein functionality as a readout for pathogenicity.
Results
A cohort of 14 individuals from 12 unrelated families exhibited highly variable clinical phenotypes, with the majority of them presenting at least one additional variant, potentially accounting for a blended phenotype and complicating phenotypic understanding. We also uncovered extreme clinical heterogeneity and high allele frequencies, occasionally incompatible with a fully penetrant recessive disorder. Human cDNA of previously described and new variants were tested in an ogdhl zebrafish knockout model, adding functional evidence for variant reclassification. We disclosed evidence of hypomorphic alleles as well as a loss-of-function variant without deleterious effects in zebrafish variant testing also showing discordant familial segregation, challenging the relationship of OGDHL as a conventional Mendelian gene. Going further, we uncovered evidence for a complex compensatory relationship among OGDH, OGDHL, and DHTKD1 isoenzymes that are associated with neurodevelopmental disorders and exhibit complex transcriptional compensation patterns with partial functional redundancy.
Conclusions
Based on the results of genetic, clinical, and functional studies, we formed three hypotheses in which to frame observations: biallelic OGDHL variants lead to a highly variable monogenic disorder, variants in OGDHL are following a complex pattern of inheritance, or they may not be causative at all. Our study further highlights the continuing challenges of assessing the validity of reported disease-gene associations and effects of variants identified in these genes. This is particularly more complicated in making genetic diagnoses based on identification of variants in genes presenting a highly heterogenous phenotype such as “OGDHL-related disorders”.
Funder
Deutsche Forschungsgemeinschaft Wellcome Trust University College London Hospitals Biomedical Research Centre
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine
Reference103 articles.
1. Molaei Ramsheh S, Erfanian Omidvar M, Tabasinezhad M, Alipoor B, Salmani TA, Ghaedi H. SUCLG1 mutations and mitochondrial encephalomyopathy: a case study and review of the literature. Mol Biol Rep. 2020;47:9699–714. 2. Donti TR, Masand R, Scott DA, Craigen WJ, Graham BH. Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant. Mol Genet Metab. 2016;119:68–74. 3. Carrozzo R, Dionisi-Vici C, Steuerwald U, Lucioli S, Deodato F, Di Giandomenico S, et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain. 2007;130:862–74. 4. Ostergaard E, Schwartz M, Batbayli M, Christensen E, Hjalmarson O, Kollberg G, et al. A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr. 2010;169:201–5. 5. Sheu KF, Blass JP. The alpha-ketoglutarate dehydrogenase complex. Ann N Y Acad Sci. 1999;893:61–78.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|